2007
DOI: 10.1089/clo.2006.0085
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Genetic Modification: Xenotransplantation And Beyond

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 14 publications
0
7
0
Order By: Relevance
“…In this article, we have shown that caffeine can rescue centrosome deterioration in aging oocytes using the porcine system as representative for most mammalian reproductive cell systems [Prather, 2007;Schatten, 2008]. We showed that the centrosome proteins g-tubulin and NuMA remain in similar configurations in aged caffeine-treated oocytes as seen in fresh oocytes, whereas oocytes aged without caffeine displayed centrosome deterioration, microtubule disorganization, and chromosome misalignment.…”
Section: Discussionmentioning
confidence: 90%
“…In this article, we have shown that caffeine can rescue centrosome deterioration in aging oocytes using the porcine system as representative for most mammalian reproductive cell systems [Prather, 2007;Schatten, 2008]. We showed that the centrosome proteins g-tubulin and NuMA remain in similar configurations in aged caffeine-treated oocytes as seen in fresh oocytes, whereas oocytes aged without caffeine displayed centrosome deterioration, microtubule disorganization, and chromosome misalignment.…”
Section: Discussionmentioning
confidence: 90%
“…A nimal cloning by somatic cell nuclear transfer (SCNT) has great potential applications in agriculture and regenerative medicine (Prather, 2007;Prather et al, 2003). Although mammalian cloning has been successfully developed over the last two decades (Wilmut et al, 1997), the success rate is low.…”
Section: Introductionmentioning
confidence: 99%
“…The gene in question codes for the protein hDAF (human decay-accelerating factor), one of the proteins that inhibits the so-called complement activation in humans (Siegert, Van Es, & Daha, 1996). Dysregulated coagulation in pig-to-primate xenotransplantation, reproduced with permission (Pierson III et al, 2009 Biotherapeutics to make an α-1,3-GalT knock-out of the Imutran pigs with an hDAF gene (Prather, 2007). Dysregulated coagulation in pig-to-primate xenotransplantation, reproduced with permission (Pierson III et al, 2009 Biotherapeutics to make an α-1,3-GalT knock-out of the Imutran pigs with an hDAF gene (Prather, 2007).…”
Section: 3) Cytos Biotechnology Is a Swiss Company Thatmentioning
confidence: 99%
“…Dysregulated coagulation in pig-to-primate xenotransplantation, reproduced with permission (Pierson III et al, 2009 Biotherapeutics to make an α-1,3-GalT knock-out of the Imutran pigs with an hDAF gene (Prather, 2007). One reason for this is that less than five percent of the islets of Langerhans in pigs have the Gal epitope, meaning that the risk of hyperacute rejection is smaller than in other pig organs (Prather, 2007). One reason for this is that less than five percent of the islets of Langerhans in pigs have the Gal epitope, meaning that the risk of hyperacute rejection is smaller than in other pig organs (Prather, 2007).…”
Section: 3) Cytos Biotechnology Is a Swiss Company Thatmentioning
confidence: 99%